News & Videos - REDCARE PHARMACY INH. - English

EQS-News: Redcare Pharmacy N.V. / Key word(s): 9 Month figures/Interim Report Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. 05.11.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. Total...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Change in Forecast/Preliminary Results Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics. 03.10.2024 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics....

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Change in Forecast/Strategic Company Decision Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated. 03-Oct-2024 / 21:57 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Half Year Results/Half Year Report Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin. 30.07.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin....

EQS-News: Redcare Pharmacy N.V. / Key word(s): Preliminary Results/Development of Sales Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2. 04.07.2024 / 06:45 CET/CEST The issuer is solely responsible for the content of this announcement. Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2. Total sales reached EUR 560M in Q2, up 33% year over year. Non-Rx sales totaled EUR 390M, steady continuation...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Miscellaneous/Product Launch Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere. 06.05.2024 / 16:57 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere. Fully digital redemption method via eGK health card and smartphone....

EQS-News: Redcare Pharmacy N.V. / Key word(s): Interim Report/Quarterly / Interim Statement Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany. 25.04.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany....

EQS-News: Redcare Pharmacy N.V. / Key word(s): Regulatory Approval Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. 23.04.2024 / 15:59 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Fully digital redemption method to be integrated in Redcare’s Shop Apotheke mobile app in Germany. Expected to be available for customers by early May. Redcare ideally positioned to...

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Regulatory Approval Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. 23-Apr-2024 / 15:56 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Today, Redcare Pharmacy has...

EQS-News: Redcare Pharmacy N.V. / Key word(s): AGM/EGM/Personnel Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board. 18.04.2024 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board. Sevenum, the Netherlands, 18 April, 2024. At Redcare...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Preliminary Results/Development of Sales Strong start of the year for Redcare Pharmacy, double-digit sales growth continues. 04.04.2024 / 06:45 CET/CEST The issuer is solely responsible for the content of this announcement. Strong start of the year for Redcare Pharmacy , double-digit sales growth continues. Total sales growth 51% year over year to EUR 560M in Q1 and 19% excluding MediService. Non-Rx sales growth 20% to EUR 404M. Active customer base...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Annual Report/Forecast Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements. 05.03.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements. Total Group sales EUR 1.8 bn, up 49%...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Personnel Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO). 04.03.2024 / 19:04 CET/CEST The issuer is solely responsible for the content of this announcement. Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO). Dirk Brüse and Lode Fastré, both long-standing...

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Personnel Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024. 04-March-2024 / 19:02 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure of inside...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Preliminary Results/Development of Sales Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance. 10.01.2024 / 06:45 CET/CEST The issuer is solely responsible for the content of this announcement. Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance. Q4 total sales EUR 531M, year-over-year growth 62%, excluding...

EQS-News: Redcare Pharmacy N.V. / Key word(s): 9 Month figures/Interim Report Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year. 31.10.2023 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year. Group sales up 67% to EUR 476M in Q3 (9M up 45% to EUR 1.3bn). Non-Rx sales...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Development of Sales/Preliminary Results Redcare Pharmacy continues to successfully grow fast in all its markets. 05.10.2023 / 06:45 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy continues to successfully grow fast in all its markets. Total sales growth 67% in Q3, to EUR 475M. Year-to-date total sales growth 45%, to EUR 1.3bn. Organic growth (i.e. excluding sales of MediService) 26% to EUR 358M in...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Half Year Report/Change in Forecast Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance. 01.08.2023 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Preliminary Results/Development of Sales Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth. 06.07.2023 / 06:45 CET/CEST The issuer is solely responsible for the content of this announcement. Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth. Total sales growth 47% to EUR 421M in Q2. Year to date sales EUR 793M, a growth of 34%. Excluding the sales of MediService...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Strategic Company Decision Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today. 13.06.2023 / 09:32 CET/CEST The issuer is solely responsible for the content of this announcement. Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leading e-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the...